Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)

BIT:1ROVI Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.31	27.19	25.32	124.95	99.04	53.16
Short-Term Investments	-	0.83	0.11	0.09	0.1	0.07
Cash & Short-Term Investments	29.31	28.02	25.44	125.03	99.14	53.23
Cash Growth	123.97%	10.15%	-79.66%	26.13%	86.22%	-21.14%
Accounts Receivable	116.24	114.83	124.55	160.23	129.8	63.34
Other Receivables	0.08	12.61	15.91	21.06	27.83	18.61
Receivables	116.33	127.44	140.46	181.28	157.63	81.95
Inventory	319.41	329.95	337.97	311.94	245.47	227.2
Prepaid Expenses	2.81	2.69	2.73	2.03	1.79	0.01
Other Current Assets	-	1.51	2.74	2.79	2.33	2.18
Total Current Assets	467.86	489.61	509.33	623.07	506.36	364.58
Property, Plant & Equipment	288.19	286.62	253.65	215.54	181.78	155.4
Long-Term Investments	19.03	19.52	0.59	2.2	2.07	1.88
Other Intangible Assets	35.87	28.23	27.74	29.14	31.51	33.93
Long-Term Deferred Tax Assets	2.96	2.26	2.34	2.08	3.85	11.11
Long-Term Deferred Charges	-	5.72	6.16	6.6	7.05	7.49
Other Long-Term Assets	0.07	0.07	0.07	0.07	0.07	0.07
Total Assets	813.96	832.02	799.88	878.7	732.68	574.44
Accounts Payable	90.84	89.93	109.89	125.87	99.4	65.19
Accrued Expenses	-	33.19	28.83	31.67	24.6	23.85
Current Portion of Long-Term Debt	23.12	17.84	8.06	8.27	2.98	2.95
Current Portion of Leases	-	5.85	5.13	4.46	3.44	3.07
Current Income Taxes Payable	7.95	2.38	5.26	-	0.68	-
Current Unearned Revenue	4.37	5.25	39.51	115.39	58.12	25.5
Other Current Liabilities	-	2.21	3.17	8.23	1.17	2.33
Total Current Liabilities	126.28	156.65	199.84	293.89	190.39	122.89
Long-Term Debt	85.27	80.5	38.58	46.04	52.52	53.94
Long-Term Leases	-	10.22	13.67	13.4	14.22	14.48
Long-Term Unearned Revenue	2.9	2.75	2.79	3.32	3.79	8.5
Long-Term Deferred Tax Liabilities	0.06	0.37	1.52	0.68	0.78	0.93
Total Liabilities	214.5	250.48	256.39	357.32	261.7	200.74
Common Stock	3.07	3.07	3.24	3.24	3.36	3.36
Additional Paid-In Capital	87.64	87.64	87.64	87.64	87.64	87.64
Retained Earnings	504.1	486.89	556.21	456.7	446.1	302.89
Treasury Stock	-4.89	-5.55	-107.68	-27.56	-66.12	-20.19
Comprehensive Income & Other	-0.04	-0.02	-0.02	-0.01	-0	-0
Total Common Equity	589.87	572.03	539.39	520.01	470.98	373.7
Minority Interest	9.6	9.51	4.11	1.37	-	-
Shareholders' Equity	599.47	581.54	543.49	521.38	470.98	373.7
Total Liabilities & Equity	813.96	832.02	799.88	878.7	732.68	574.44
Total Debt	108.38	114.41	65.43	72.17	73.16	74.44
Net Cash (Debt)	-79.08	-86.39	-39.99	52.87	25.97	-21.21
Net Cash Growth	-	-	-	103.55%	-	-
Net Cash Per Share	-1.55	-1.69	-0.75	0.99	0.47	-0.38
Filing Date Shares Outstanding	51.15	51.15	51.82	53.37	54.85	55.4
Total Common Shares Outstanding	51.15	51.15	51.82	53.37	54.85	55.4
Working Capital	341.58	332.96	309.49	329.19	315.97	241.69
Book Value Per Share	11.53	11.18	10.41	9.74	8.59	6.75
Tangible Book Value	554	543.8	511.65	490.87	439.46	339.77
Tangible Book Value Per Share	10.83	10.63	9.87	9.20	8.01	6.13
Land	-	74.8	60.65	45.12	37.25	35.75
Machinery	-	404.19	372.97	303.78	275.44	250.22
Construction In Progress	-	11.01	8.47	40.17	28.06	14.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.